The invention relates to a solid pharmaceutical preparation containing water-soluble salts of Levothyroxine and/or Liothyronine as active agent, whereinwater activity of the pharmaceutical preparation measured at room temperatureis set to values below 0.4, preferably 0.1 to 0.3.
展开▼